FDA cleared the ulrichINJECT CT Motion (XD 8000) from Ulrich GmbH & Co. KG on Nov 7, 2025 under K251295, a traditional 510(k). The device falls under product code IZQ, Injector, Contrast Medium, Automatic, regulated at 21 CFR 870.1650 as a Class 2 device. The review panel was Cardiovascular.

FDA logged the submission as received on Apr 25, 2025. The decision came 196 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

Ulrich GmbH & Co. KG has 2 other decisions in the tracker over the last 12 months: K252087 (Navigation Module of the CortiumĀ® System), K252281 (ulricheasyINJECT Max 2M (XD 10140); ulricheasyINJECT Max 3 (XD 10150); ulricheasyINJECT Max 3 (XD 10180)).